Kcentra (prothrombin complex concentrate) is prescribed to treat specific blood clotting problems. It’s usually given in a hospital in emergency situations. Kcentra’s cost may depend on dosage, ...
CSL Behring today announced that Kcentra ® (Prothrombin Complex Concentrate [Human]) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication -- urgent reversal of ...
KCENTRA (prothrombin complex concentrate [human]) 500 Units The FDA has approved the expanded indication for Kcentra (Prothrombin Complex Concentrate [Human]; CSL Behring) to include the urgent ...
WASHINGTON, April 30 (UPI) -- The U.S. Food and Drug Administration approved Kcentra for the urgent reversal of vitamin K antagonist anti-coagulation in adults with acute major bleeding. "The FDA's ...
Here are two small but important changes in the anticoagulation field: FDA approves new product for urgent reversal of anticoagulation. The FDA yesterday approved Kcentra (Prothrombin Complex ...
The 94.3% efficacy of the Octapharma product was just a shade ahead of the 94.2% measured in a comparative product, Kcentra. Results of a Phase III study (LEX-209) of the safety and efficacy of ...
The US Food and Drug Administration (FDA) has approved Kcentra (prothrombin complex concentrate), a new biological treatment indicated for the urgent reversal of vitamin K antagonist (VKA), a class of ...
The recall notification is due to a potential risk of breakage of the glass vials during transport because of a change in the secondary packaging configuration. CSL Behring is recalling certain lots ...
Bleeding out, or the rapid loss of blood, is the most common cause of preventable death after injury. Researchers at Baylor College of Medicine and Ben Taub Hospital, part of Harris Health System, are ...
KING OF PRUSSIA, Pa., March 17, 2015 /PRNewswire/ -- CSL Behring today announced that The Lancet has published results from a Phase III clinical study showing Kcentra (Prothrombin Complex Concentrate ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results